DE3486235D1 - Fettsäure-Zusammensetzungen. - Google Patents

Fettsäure-Zusammensetzungen.

Info

Publication number
DE3486235D1
DE3486235D1 DE84304610T DE3486235T DE3486235D1 DE 3486235 D1 DE3486235 D1 DE 3486235D1 DE 84304610 T DE84304610 T DE 84304610T DE 3486235 T DE3486235 T DE 3486235T DE 3486235 D1 DE3486235 D1 DE 3486235D1
Authority
DE
Germany
Prior art keywords
fatty acid
acid compositions
efa
gamma
linolenic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE84304610T
Other languages
English (en)
Other versions
DE3486235T2 (de
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Efamol Ltd
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Publication of DE3486235D1 publication Critical patent/DE3486235D1/de
Application granted granted Critical
Publication of DE3486235T2 publication Critical patent/DE3486235T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE84304610T 1983-07-14 1984-07-05 Fettsäure-Zusammensetzungen. Expired - Fee Related DE3486235T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838319073A GB8319073D0 (en) 1983-07-14 1983-07-14 Fatty acid compositions

Publications (2)

Publication Number Publication Date
DE3486235D1 true DE3486235D1 (de) 1993-12-02
DE3486235T2 DE3486235T2 (de) 1994-04-14

Family

ID=10545711

Family Applications (1)

Application Number Title Priority Date Filing Date
DE84304610T Expired - Fee Related DE3486235T2 (de) 1983-07-14 1984-07-05 Fettsäure-Zusammensetzungen.

Country Status (9)

Country Link
EP (1) EP0132089B1 (de)
JP (1) JPS6038324A (de)
AT (1) ATE96313T1 (de)
AU (1) AU562938B2 (de)
CA (1) CA1251736A (de)
DE (1) DE3486235T2 (de)
GB (1) GB8319073D0 (de)
HK (1) HK37694A (de)
IE (1) IE61082B1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
SE8505569D0 (sv) * 1985-11-25 1985-11-25 Aco Laekemedel Ab Enteralt preparat
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
IT1223290B (it) 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
US5866150A (en) * 1996-03-20 1999-02-02 Aquaculture Technology Incorporated Antibacterially active extracts from the marine algae chaetoceros and methods of use
GB9901808D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Drugs for treatment of psychiatric and brain disorders
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
US6320062B1 (en) 1999-11-09 2001-11-20 Alcon Universal Ltd. 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
CA2388030A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
AU1226001A (en) 1999-11-09 2001-06-06 Alcon Universal Limited Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
KR20020050239A (ko) 1999-11-09 2002-06-26 구이도 콜러, 스테판 바슬러 하이드록시에이코사테트라엔산 유도체를 함유하는 조성물및 안구 건조증 치료에서의 사용 방법
WO2001034553A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
TR200201251T2 (tr) 1999-11-09 2002-11-21 Alcon, Inc. Omega zinciri tadil edilmiş 15-hidroksieikosatetraenoik asit türevleri ve bunların göz kurumasının iyileştirilmesi için kullanım yöntemleri
CA2386623A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
CA2388044A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
DK1228026T3 (da) 1999-11-09 2004-04-05 Alcon Inc 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
DE60010503T2 (de) 1999-11-09 2004-09-23 Alcon, Inc. Tri-heteroatom-substituierte und zwei kohlenstoff homologe von 15-hete und verfahren zur verwendung
EA200301204A1 (ru) * 2001-04-30 2004-04-29 Тромсдорф ГмбХ унд Ко.КГ Арцнаймиттель Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
AU2003235454A1 (en) 2002-06-14 2003-12-31 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
US20040044079A1 (en) * 2002-09-04 2004-03-04 The Iams Company Methods and compositions for weight control
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
SG10201912145VA (en) 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082624A (en) * 1965-02-26 1967-09-06 Calmic Ltd Improvements in or relating to therapeutically active compounds
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition

Also Published As

Publication number Publication date
EP0132089A1 (de) 1985-01-23
GB8319073D0 (en) 1983-08-17
IE841738L (en) 1985-01-14
HK37694A (en) 1994-04-29
AU562938B2 (en) 1987-06-25
CA1251736A (en) 1989-03-28
ATE96313T1 (de) 1993-11-15
EP0132089B1 (de) 1993-10-27
IE61082B1 (en) 1994-09-21
AU3057784A (en) 1985-01-17
DE3486235T2 (de) 1994-04-14
JPS6038324A (ja) 1985-02-27

Similar Documents

Publication Publication Date Title
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
NO932983L (no) Fettsyrebehandling
SE8902701L (sv) Fettsyrakomposition
EP0303915A3 (en) Retinoids for the treatment of skin damaged by light
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
ES2107622T3 (es) Medicamento para el tratamiento de la distrofia vulvar o la sequedad vaginal.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
ATE32430T1 (de) Pharmazeutische zusammensetzungen.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
ATE22804T1 (de) Pharmazeutische zusammensetzung.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
OA08843A (fr) Nouvelle composition ophtalmologique.
ATE63684T1 (de) Deodorant.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
NO874241D0 (no) Terapeutisk aktive salter.
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee